IMFINZI 50 mg/mL concentrate for solution for infusion.
D419QL00009
Phase 3 small_molecule active
Quick answer
IMFINZI 50 mg/mL concentrate for solution for infusion. for small cell lung cancer is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- small cell lung cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active